Get startedLog in
    Picture of Chosa Oncology AB logo

    CHOSA — Chosa Oncology AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: RhoVac Gets Approval In Sweden To Start Clinical Phase IIb Trial

    Picture of Chosa Oncology AB logoChosa Oncology AB
    22/06/2020 15:25
    June 22 (Reuters) - RhoVac AB  RHOVAC.TE :
    * RHOVAC RECEIVES APPROVAL IN SWEDEN TO START CLINICAL PHASE
IIB
TRIAL
    * CLINICAL PHASE IIB TRIAL IS AN INTERNATIONAL STUDY THAT IS
EXPECTED TO RECRUIT AT LEAST 175 PATIENTS IN SIX EUROPEAN
COUNTRIES (DENMARK, FINLAND, SWEDEN, UNITED KINGDOM, BELGIUM AND
GERMANY) AS WELL AS IN UNITED STATES

Source text for Eikon:  ID:nWkr53PfR2 
Further company coverage:  RHOVAC.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

    Recent news on Chosa Oncology AB

    See all news